The TCGA melanoma cohort was sub-grouped into well-differentiated and poorly differentiated tumors based on expression of the differentiation drivers microphthalmia transcription factor (MIFT) and AXL, a member of the TAM family of receptor tyrosine kinases. The gene discussed is AXL; the disease is melanoma.